Stay updated on Nivolumab+RT+Bevacizumab in Recurrent Methylated Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab+RT+Bevacizumab in Recurrent Methylated Glioblastoma Clinical Trial page.

Latest updates to the Nivolumab+RT+Bevacizumab in Recurrent Methylated Glioblastoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedPage revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check52 days agoChange DetectedThe change updates the page revision from v3.4.1 to v3.4.2, with no observed changes to study details or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check60 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1. This update does not affect study information or user-facing content.SummaryDifference0.0%

- Check74 days agoChange DetectedThe page now displays 'Last Update Posted' instead of 'Last Update Posted (Estimated)', removing the estimated tag from the update timestamp. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check82 days agoChange DetectedA new 'Last Update Posted (Estimated)' field was added and the revision label updated to 'v3.3.4', replacing the previous 'Last Update Posted' field and 'Revision: v3.3.3'.SummaryDifference0.1%

Stay in the know with updates to Nivolumab+RT+Bevacizumab in Recurrent Methylated Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab+RT+Bevacizumab in Recurrent Methylated Glioblastoma Clinical Trial page.